The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions
Behavioral and psychological symptoms of dementia (BPSD) afflict the vast majority of patients with dementia, especially those with Alzheimer’s disease (AD). In clinical settings, patients with BPSD most often do not present with just one symptom. Rather, clusters of symptoms commonly co-occur and c...
Main Authors: | Rachel M. Keszycki, Daniel W. Fisher, Hongxin Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01109/full |
Similar Items
-
Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
by: Millán-Calenti JC, et al.
Published: (2016-02-01) -
A nursing mentoring programme on non‐pharmacological interventions against BPSD: Effectiveness and use of antipsychotics—A retrospective, before–after study
by: Roxane Plante‐Lepage, et al.
Published: (2022-01-01) -
Can a personalised music listening intervention decrease agitation in hospitalised patients with dementia? A feasibility trial
by: Shanna Lee, et al.
Published: (2023-08-01) -
Effect of the WeCareAdvisor™ on family caregiver outcomes in dementia: a pilot randomized controlled trial
by: Helen C. Kales, et al.
Published: (2018-05-01) -
Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
by: E. G. Mendelevich
Published: (2018-11-01)